Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Cost of Revenue (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Cost of Revenue for 17 consecutive years, with $518.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 12.85% year-over-year to $518.0 million, compared with a TTM value of $1.8 billion through Dec 2025, changed 0.27%, and an annual FY2025 reading of $1.8 billion, changed 0.27% over the prior year.
  • Cost of Revenue was $518.0 million for Q4 2025 at Dentsply Sirona, up from $463.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $518.0 million in Q4 2025 and bottomed at $413.0 million in Q1 2025.
  • Average Cost of Revenue over 5 years is $461.6 million, with a median of $459.0 million recorded in 2023.
  • The sharpest move saw Cost of Revenue skyrocketed 47.32% in 2021, then dropped 7.61% in 2025.
  • Year by year, Cost of Revenue stood at $499.0 million in 2021, then decreased by 6.61% to $466.0 million in 2022, then increased by 5.15% to $490.0 million in 2023, then dropped by 6.33% to $459.0 million in 2024, then rose by 12.85% to $518.0 million in 2025.
  • Business Quant data shows Cost of Revenue for XRAY at $518.0 million in Q4 2025, $463.0 million in Q3 2025, and $446.0 million in Q2 2025.